Brief introduction of Nanjing Laoshan pharmaceutical co., ltd

Nanjing Laoshan Pharmaceutical Co., Ltd. produces more than 30 varieties and more than 40 specifications of drugs and health products such as "Laoshan" brand royal jelly freeze-dried powder, Weilening tablets and Coriolus versicolor polysaccharide capsules. The main products, Laoshan brand royal jelly freeze-dried powder and capsules, have become the only products in Jiangsu Province that have successfully applied for the standard name of national medicine, and are "famous brand products in Jiangsu Province". The company's "National Customer Satisfaction Products" has been in the leading position in the domestic bee products industry for five consecutive years, with a domestic market share of over 60%, and exported to Europe, America, Southeast Asia and other countries. Nanjing Laoshan pharmaceutical co., ltd is located in the beautiful Laoshan national forest. It is a national key leading enterprise in agricultural industrialization controlled by Nanjing Agricultural Reclamation Industry Group, Shanghai Fosun Group and company executives. The company is mainly engaged in the research and development, production and sales of bee series health care products and mushroom series Chinese patent medicines. A series of bee products, mainly the famous brand "Laoshan" brand royal jelly freeze-dried powder in Jiangsu, have occupied 60% of the domestic market and are also one of the major brands for foreign trade export. The company has extensively carried out scientific research cooperation at home and abroad and established green pollution-free bases all over the country. Laoshan Pharmaceutical Co., Ltd. is the vice president of China Bee Products Association and the chairman of Royal Jelly Professional Committee. Authorized by the State Administration of Pharmaceutical Products, it has formulated the national standard for freeze-dried royal jelly series drugs. At present, Laoshan Pharmaceutical has passed ISO:2000 and GMP certification, and the company's net profit in recent years shows good growth and strong profitability of its main business. A standardized biopharmaceutical industry, which integrates the concepts of biopharmaceuticals, agriculture, performance and high growth, is entering a new development period.